L. Weissfloch et al., A new Class of Drugs for BNCT? Borylated derivatives of ferrocenium compounds in animal experiments, BIOMETALS, 14(1), 2001, pp. 43-49
A new class of drugs, borylated derivatives of ferrocenium compounds, which
show a comparatively facile synthesis is investigated on their boron neutr
on capture accumulation. Investigations focused on the fast and effective t
esting of 12 ferrocene derivatives with tetracoordinated boron atoms, which
should accumulate in rodent tumors. The macroscopic studies on time-depend
ent boron distributions and boron concentrations in mice were carried out b
y inductively coupled plasma-atomic emission spectrometry, inductively coup
led plasma-mass spectrometry, and quantitative neutron capture radiography.
The determination of boron concentrations after injection of 2b showed hig
h boron contents in spleen, liver, kidneys, less in lung and muscle, and po
or in integral blood, blood plasma, tumor, and brain. It is interesting to
note that 2b penetrates the blood-brain barrier which may be advantageous i
n the treatment of astrocytomas and glioblastomas.